GLP‑1 receptor agonists such as semaglutide—marketed under the brand names Ozempic and Wegovy—have become prominent in discussions about weight loss. While Ozempic remains FDA‑approved only for type 2 diabetes, it is frequently prescribed off‑label for overweight and obesity, much like certain anxiolytics are used for anxiety symptoms. Common gastrointestinal side effects include nausea, diarrhea, and abdominal pain.
In recent months a new term has emerged in the GLP‑1 community: “Ozempic face.” This phrase describes facial changes that can occur after rapid weight loss, such as sagging skin, the appearance of new wrinkles, and a hollowed look around the cheeks and neck. Though not an official medical diagnosis, the term was first coined by cosmetic dermatologist Dr. Paul Jarrod Frank, who noticed an uptick in patients seeking help for these changes.
Rather than the medication itself causing facial alterations, the effects are largely a consequence of rapid fat loss. When weight is shed quickly, the subcutaneous tissue that once supported the skin’s contour is removed, leading to loose or sagging skin. This process is not unique to GLP‑1 drugs; it can affect any body area—including the abdomen, thighs, and arms—when fat loss is swift. The loss of subcutaneous fat also reduces collagen production and skin elasticity, further contributing to the appearance of loose or wrinkled skin.
Gradual weight loss, in contrast, allows the skin more time to adjust, potentially mitigating sagging. While the exact prevalence of “Ozempic face” remains unclear, a 2025 systematic review in the Aesthetic Surgery Journal identified a possible link between increased GLP‑1 use and a rise in cosmetic procedures. As GLP‑1 therapies become more common in the U.S., further clinical research will likely clarify the incidence and management of facial skin changes associated with these medications.
In summary, the so‑called “Ozempic face” is best understood as a natural, though sometimes noticeable, consequence of rapid weight loss rather than a direct side effect of the drug itself. Understanding the underlying biology can help patients set realistic expectations and explore options for maintaining skin tone during their weight‑loss journey.
